Enhanced renal function in bradykinin B(2) receptor transgenic mice.
@article{Wang2000EnhancedRF,
title={Enhanced renal function in bradykinin B(2) receptor transgenic mice.},
author={D. Z. Wang and Hideaki Yoshida and Qing Song and Lee Chao and Julie Chao},
journal={American journal of physiology. Renal physiology},
year={2000},
volume={278 3},
pages={
F484-91
}
}The tissue kallikrein-kinin system has been recognized as a paracrine and/or autocrine hormonal system that regulates arterial pressure, renal hemodynamics, and electrolyte excretion. We have created a transgenic mouse model overexpressing human bradykinin B(2) receptor, and the mice developed lifetime hypotension. With this animal model, we further analyzed the potential role of B(2) receptors in regulation of renal function. Baseline urinary excretion, urinary potassium excretion, and pH were…
39 Citations
Decreased renal NO excretion and reduced glomerular tuft area in mice lacking the bradykinin B2 receptor.
- Biology, MedicineAmerican journal of physiology. Heart and circulatory physiology
- 2003
Backcrossed B(2)-/- mice had normal blood pressure and normal apparent renal hemodynamics and morphology, however, reduced renal nitrite excretion and glomerular cGMP content were found, which was associated with a reducedglomerular capillary surface area.
Mechanisms of Disease: the tissue kallikrein–kinin system in hypertension and vascular remodeling
- Medicine, BiologyNature Clinical Practice Nephrology
- 2007
Development of novel therapeutic approaches to bolster kinin activity in the vascular wall and in specific compartments in the kidney might be a highly effective strategy for the treatment of hypertension and its complications, including cardiac hypertrophy and renal failure.
Normal Blood Pressure and Renal Function in Mice Lacking the Bradykinin B2 Receptor
- Biology, MedicineHypertension
- 2001
The data suggest that the absence of B2 receptor function does not necessarily make B1 receptor knockout mice hypertensive or induce salt sensitivity, and that differences in the genetic background or an adaptation to the loss of B 2 receptor function may account for these results.
The Bradykinin B2 receptor is required for full expression of renal COX-2 and renin
- Biology, MedicinePeptides
- 2003
Role of bradykinin in angiotensin-converting enzyme knockout mice.
- BiologyAmerican journal of physiology. Heart and circulatory physiology
- 2003
A line of mice deficient in both the B(2) receptor and ACE did not differ from ACE knockout mice in blood pressure, urine concentrating ability, renal pathology, and hematocrit, suggesting abnormalities of bradykinin accumulation do not play an important role in the ACE knockout phenotype.
Delivery of recombinant adeno-associated virus-mediated human tissue kallikrein for therapy of chronic renal failure in rats.
- Biology, MedicineHuman gene therapy
- 2008
Restoration of the kallikrein-kinin system reduces kidney injury and protects renal function in 5/6-nephrectomized rats via changes in the expression and activation of G protein-coupled receptors including B(2)R.
Angiotensin-converting enzyme II in the heart and the kidney.
- Biology, MedicineCirculation research
- 2006
ACE2 not only controls angiotensin II levels but functions as a protease on additional molecular targets that could contribute to the observed in vivo phenotypes of ACE2 mutant mice, suggesting that ACE2 seems to be a molecule that has protective roles in heart and kidney.
Cross talk between kinin and angiotensin II receptors in mouse abdominal aorta
- Biology, MedicineBiological chemistry
- 2009
It is concluded that cross talk between kinin and AngII receptors occurs in mouse abdominal aorta and that both peptides may regulate the initiation and progression of important pathophysiological processes, such as hypertension and inflammation.
Angiotensin II–Induced Hypertension in Bradykinin B2 Receptor Knockout Mice
- Biology, MedicineHypertension
- 2001
It is demonstrated that the kallikrein-kinin system selectively buffers the vasoconstrictor activity of Ang II, and the enhanced susceptibility of B2R−/− mice to Ang II–induced hypertension and renal vasconstriction is likely due to an impaired ability to release NO by endogenous kinins.
Angiotensin II – Induced Hypertension in Bradykinin B 2 Receptor Knockout Mice
- Biology, Medicine
- 2001
It is demonstrated that the kallikrein-kinin system selectively buffers the vasoconstrictor activity of Ang II and the enhanced susceptibility of B2R 2/2 mice to Ang II–induced hypertension and renal vasconstriction is likely due to an impaired ability to release NO by endogenous kinins.
References
SHOWING 1-10 OF 56 REFERENCES
Potassium supplement upregulates the expression of renal kallikrein and bradykinin B2 receptor in SHR.
- Biology, MedicineThe American journal of physiology
- 1999
This study suggests that upregulation of the tissue kallikrein-kinin system may be attributed, in part, to blood pressure-lowering and diuretic effects of high potassium intake.
Salt-sensitive hypertension in bradykinin B2 receptor knockout mice.
- Biology, MedicineBiochemical and biophysical research communications
- 1996
The hypothesis that mice lacking the gene encoding for the bradykinin B2 receptor (B2-KO) have a greater hypertensive response to chronic high Na+ intake (salt sensitivity) compared to controls is tested and kinins play a role in preventing salt-sensitive hypertension.
Hypotension in transgenic mice overexpressing human bradykinin B2 receptor.
- Biology, MedicineHypertension
- 1997
These studies show that overexpression of human bradykinin B2 receptor causes a sustained reduction of blood pressure in transgenic mice and suggest that the B 2 receptor-mediated signal transduction pathway plays a role in blood pressure regulation.
Bradykinin B2 receptor modulates renal prostaglandin E2 and nitric oxide.
- Medicine, BiologyHypertension
- 1997
The failure of icatibant to change renal function after inhibition of cyclooxygenase and nitric oxide synthase activity suggests that the effects of kinin B2 receptor are mediated by intrarenal prostaglandin E2 and nitRIC oxide generation.
Human kallikrein gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in Dahl salt-sensitive rats.
- Biology, MedicineHuman gene therapy
- 1998
Adenovirus-mediated gene delivery in Dahl-SS rats fed a high-salt diet resulted in prolonged reduction of blood pressure and increased urinary kinin and cGMP levels, consistent with blood pressure reductions mediated via kinin through a cG MP-dependent signal transduction pathway.
Enhanced blood pressure sensitivity to deoxycorticosterone in mice with disruption of bradykinin B2 receptor gene.
- Medicine, BiologyHypertension
- 1998
Results show that integrity of the bradykinin B2 receptor is essential for regulation of blood pressure and heart rate under basal conditions and indicate that activation of the kallikrein-kinin system represents a compensatory response against the development of hypertension induced by mineralocorticoid excess.
Long-term infusion of kallikrein attenuates renal injury in Dahl salt-sensitive rats.
- Biology, MedicineAmerican journal of hypertension
- 1997
Hypertension induced by a nonpressor dose of angiotensin II in kininogen-deficient rats.
- Biology, MedicineHypertension
- 1994
The results suggest that the lack of kinin generation observed in the kininogen-deficient rats may cause the hypertensive response during the administration of a nonpressor dose of Ang II mainly through sodium retention probably caused by aldosterone release.
High level of circulating human tissue kallikrein induces hypotension in a transgenic mouse model.
- BiologyClinical and experimental hypertension
- 1996
It is shown that over-production of tissue kallikrein in the circulation plays a role in blood pressure regulation.
Angiotensinogen gene null-mutant mice lack homeostatic regulation of glomerular filtration and tubular reabsorption.
- Biology, MedicineKidney international
- 1998
Angiotensin is essential for the two fundamental homeostatic functions of the mammalian kidney, namely stable GFR and high urine diluting and concentrating capacity during alteration in extracellular fluid (ECF) volume.




